At AES Environmental, we understand the critical role of containment equipment in ensuring the safety and efficacy of pharmaceutical operations. In our latest article, we delve into the nuanced comparison between cytotoxic drug safety cabinets (CDSCs) and pharmaceutical isolators. We’ll explore recent findings that highlight the benefits of CDSCs, examining aspects such as ease of cleaning, material transfer process, and operational training. Our focus is on guiding you towards making informed decisions in your pharmaceutical setting, balancing practicality, safety, and efficiency in handling cytotoxic drugs.

View the full article here

Complex Cleaning and Maintenance: Discussing the contrast in cleaning and maintenance between pharmaceutical isolators and cytotoxic drug safety cabinets. Isolators, due to their enclosed design, present challenges in thorough cleaning and maintenance. The open design of Cytotoxic Drug Safety Cabinets allows for easier and more effective cleaning.

Material Transfer Process: The process of transferring materials in and out of containment systems is critical. Pharmaceutical isolators often require a complex, multistage process for material transfer. CDSC’s offer a simple and direct material transfer process, enhancing both the safety and efficiency of drug preparation.

Operational Training and Experience: The challenges of operating a system with greater complexity are felt by all. Isolators, while offering protection against external contamination, are more prone to microbial growth due to cleaning and material transfer challenges. A study cited shows a higher rate of microbial contamination in isolators compared to CDSCs.

Initial and Ongoing Costs of Operating an Isolator: Costs associated with pharmaceutical isolators are typically far greater than Cytotoxic Drug Safety Cabinets. Isolators, owing to their complex design, have higher initial and maintenance costs. In contrast, CDSCs, while maintaining safety standards, have a simpler design leading to lower initial and ongoing costs, making them a more cost-effective option for facilities with budget constraints.

View our range of Cytotoxic Drug Safety Cabinets

AES Environmental is excited to announce the capacity to provide AS1324 NATA testing for Air Filters within it’s laboratory based in Sydney, NSW. NATA is an independent testing organisation responsible for accrediting AS1324 test facilities in Australia. The Covid Pandemic highlighted the need for greater compliance and repeatability when testing air filtration products, Australia is once again raising that bar.

The specific scopes we are validated for include:

  1. Initial resistance (Pressure differential, AS1324.2 Section 2)
  2. Mass stabilisation (Gravimetric, AS1324.2 Section 3)
  3. Efficiency – Test dust No.1 (Photometric, AS1324.2 Section 4)
  4. Gravimetric – Test dust No.4 (Gravimetric, AS1324.2 Section 5)

NATA is an signatory to the ILAC (International Laboratory Accreditation Cooperation) mutual recognition agreement (MRA). NATA is one of 113 accreditation bodies from over 117 economies to have signed the MRA. ILAC’s primary goals include developing and aligning accreditation practices for various bodies, recognizing accredited laboratories and providers globally, and advocating for accreditation acceptance among industry, governments, regulators, and consumers. About ILAC.

A truly Global Accreditation. For more information on Air Filter testing, check out our previous post here or connect.

With this accreditation, we are able to offer this service for local and International customers wishing to certify their Air filters to the Australian Standards

For more information on our scope of accreditation click here

At AES Environmental, we’re excited to share our recent success at the NSW Premier’s Export Awards. We’re honored to announce that we received the prestigious ECA Global Achievement Award, a testament to our unwavering dedication to the New South Wales export market and our relentless commitment to advancing as an engineering and manufacturing organization.

Our Biological Safety Cabinets and other Laminar Flow products have witnessed remarkable growth over the past year, expanding into new markets. We maintain a steadfast focus on continuous product development to propel Australian manufacturing to new heights..

Our vision extends beyond the export market. We’re fervently invested in bolstering Australian manufacturing, diversifying our product portfolio, and expanding our operational capability. A significant milestone in this endeavor was the recent accreditation of our AS 1324 test facility by NATA, signaling just the beginning of a planned investment in technical and manufacturing capabilities set to unfold in 2024 and beyond.

In the months to come, we’re set to launch an array of innovative products, including a groundbreaking HEPA module and an advanced Class II Biological Safety Cabinet, reinforcing our position as an industry leader. We firmly believe that Australia boasts a unique blend of manufacturing potential, a highly skilled workforce, and the relentless Aussie spirit. It is with great enthusiasm that we commit to further enhancing our manufacturing capabilities in Australia.

While our nominations at the NSW Premier’s Export Awards didn’t result in victory, we certainly relished a fantastic evening of celebration alongside our esteemed peers. We extend our heartfelt congratulations to the businesses that clinched the honors, and eagerly anticipate our continued presence in the competition in 2024.

Our heartfelt gratitude goes out to our dedicated employees, our loyal customers, and all those who have acknowledged our efforts and provided unwavering support on this remarkable journey. With your continued support, we’re poised to reach even greater heights in the field of engineering and manufacturing. Thank you for being part of this exciting adventure with AES Environmental.

We are thrilled to announce our latest milestone. Effective from 1st July 2023, we have successfully acquired the air filter business interests of AES Environmental (WA) Pty Ltd, continuing our drive to expand our Australian sales and manufacturing operations.

This strategic investment, coupled with our recent investments, expanding our manufacturing capabilities and air filter test rigs, strengthens our position in the Australian market.

We extend a warm welcome to the employees of AES Environmental (WA), assuring them of continuity and stability within our growing business. Customers and Suppliers will be notified separately about any changes to payment and banking arrangements.

AMCCS takes pride in licensing iconic Australian filter brands, including Clyde-Apac (1923), Vokes (1939), and Email Air Handling (1958), and our commitment to quality is reinforced by our retained air filter test rigs in our IEC 17025 laboratory in NSW.

To learn more about our company, products, and capabilities, please visit our website at For media inquiries, kindly contact us at, and for supplier-related queries, please reach out to

Original press release

Concerns regarding the status of AS 1324.2:2003 as a test standard for air filter efficiency have been addressed. The recent edition of the ABCB handbook ‘Indoor Air Quality Verification Methods’ confirms that AS 1324.2:2003 remains relevant and applicable for Performance Solutions and Deemed-to-Satisfy (DTS) Solutions, for the purposes of the NCC (National Construction Code). The handbook provides guidance for designers and installers, listing AS 1324.2:2003 as one of the suitable test standards for air filter efficiency. For DTS Solutions, AS 1324.2:2003 is the only applicable test standard.

The updated handbook is available on the ABCB website.

#AirQuality #Standards #Ventilation